Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,693 | N/A |
| Depreciation Amortization | 585 | N/A |
| Other Working Capital | -48 | N/A |
| Other Operating Activity | 405 | 0 |
| Operating Cash Flow | $-4,751 | $N/A |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 2,865 | N/A |
| PPE Investments | -76 | N/A |
| Other Investing Activity | -9 | 0 |
| Investing Cash Flow | $2,780 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 4,682 | N/A |
| Financing Cash Flow | $4,682 | $N/A |
| Exchange Rate Effect | -369 | N/A |
| Beginning Cash Position | 3,389 | N/A |
| End Cash Position | 5,731 | N/A |
| Net Cash Flow | $2,342 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -4,751 | N/A |
| Capital Expenditure | -76 | N/A |
| Free Cash Flow | -4,827 | 0 |